pregabalin 150 mg

1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: neuropathic pain associated with diabetic peripheral neuropathy (DPN). (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older. (1) fibromyalgia (1) neuropathic pain associated with spinal cord injury. (1)

Amneal Pharmaceuticals NY LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] pain` `[5] off label use` `[6] diarrhoea` `[7] headache` `[8] dizziness` `[9] fall` `[10] dyspnoea`

4 years ago

CAPSULE WHITE AN 1314

16 HOW SUPPLIED/STORAGE AND HANDLING

PREGABALIN capsules, 25 mg are supplied as white, hard gelatin capsule printed with black ink “AN” on cap & “1310” on body. They are available as follows: Bottles of 90: NDC 69238-1310-9 Bottles of 500: NDC 69238-1310-5

PREGABALIN capsules, 50 mg are supplied as white, hard gelatin capsule printed with black ink “AN” on cap & “1311” on body. They are available as follows: Bottles of 90: NDC 69238-1311-9 Bottles of 500: NDC 69238-1311-5

PREGABALIN capsules, 75 mg are supplied as white/orange, hard gelatin capsule printed with black ink “AN” on cap & “1312” on body. They are available as follows: Bottles of 90: NDC 69238-1312-9 Bottles of 500: NDC 69238-1312-5

PREGABALIN capsules, 100 mg are supplied as orange, hard gelatin capsule printed with black ink “AN” on cap & “1313” on body. They are available as follows: Bottles of 90: NDC 69238-1313-9 Bottles of 500: NDC 69238-1313-5

PREGABALIN capsules, 150 mg are supplied as white, hard gelatin capsule printed with black ink “AN” on cap & “1314” on body. They are available as follows: Bottles of 90: NDC 69238-1314-9 Bottles of 500: NDC 69238-1314-5

PREGABALIN capsules, 200 mg are supplied as light orange, hard gelatin capsule printed with black ink “AN” on cap & “1315” on body. They are available as follows: Bottles of 90: NDC 69238-1315-9 Bottles of 500: NDC 69238-1315-5

PREGABALIN capsules, 225 mg are supplied as white/light orange, hard gelatin capsule printed with black ink “AN” on cap & “1316” on body. They are available as follows: Bottles of 90: NDC 69238-1316-9 Bottles of 500: NDC 69238-1316-5

PREGABALIN capsules, 300 mg are supplied as white/orange, hard gelatin capsule printed with black ink “AN” on cap & “1317” on body. They are available as follows: Bottles of 90: NDC 69238-1317-9 Bottles of 500: NDC 69238-1317-5 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in tight (USP), child-resistant containers.

More pills like CAPSULE AN 1314

Related Pills

pregabalin 300 mg

Amneal Pharmaceuticals NY LLC

pregabalin 225 mg

Amneal Pharmaceuticals NY LLC

pregabalin 200 mg

Amneal Pharmaceuticals NY LLC

pregabalin 75 mg

Amneal Pharmaceuticals NY LLC

pregabalin 50 mg

Amneal Pharmaceuticals NY LLC

pregabalin 25 mg

Amneal Pharmaceuticals NY LLC

pregabalin 100 mg

amneal pharmaceuticals ny llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site